CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | -99.1% | 267 | -98.9% | 0.00% | – |
Q1 2021 | $117,000 | -52.2% | 23,400 | +20.6% | 0.00% | – |
Q4 2020 | $245,000 | +28.3% | 19,400 | 0.0% | 0.00% | – |
Q3 2020 | $191,000 | -1.0% | 19,400 | 0.0% | 0.00% | – |
Q2 2020 | $193,000 | +12.9% | 19,400 | 0.0% | 0.00% | – |
Q1 2020 | $171,000 | -3.9% | 19,400 | +0.5% | 0.00% | – |
Q4 2019 | $178,000 | +26.2% | 19,300 | -19.6% | 0.00% | – |
Q3 2019 | $141,000 | -51.0% | 24,000 | 0.0% | 0.00% | – |
Q2 2019 | $288,000 | -6.2% | 24,000 | -5.5% | 0.00% | – |
Q1 2019 | $307,000 | -3.8% | 25,400 | 0.0% | 0.00% | – |
Q4 2018 | $319,000 | -15.4% | 25,400 | 0.0% | 0.00% | – |
Q3 2018 | $377,000 | -47.6% | 25,400 | -40.6% | 0.00% | -100.0% |
Q2 2018 | $720,000 | -4.4% | 42,794 | +30.1% | 0.00% | 0.0% |
Q1 2018 | $753,000 | +20.7% | 32,884 | +36.3% | 0.00% | 0.0% |
Q4 2017 | $624,000 | +161.1% | 24,131 | +49.0% | 0.00% | – |
Q3 2017 | $239,000 | +5.8% | 16,200 | 0.0% | 0.00% | – |
Q2 2017 | $226,000 | -18.1% | 16,200 | -0.0% | 0.00% | – |
Q1 2017 | $276,000 | +65.3% | 16,201 | +0.0% | 0.00% | – |
Q4 2016 | $167,000 | +1.8% | 16,200 | 0.0% | 0.00% | – |
Q3 2016 | $164,000 | -9.9% | 16,200 | 0.0% | 0.00% | – |
Q2 2016 | $182,000 | -17.6% | 16,200 | 0.0% | 0.00% | – |
Q1 2016 | $221,000 | -28.0% | 16,200 | 0.0% | 0.00% | – |
Q4 2015 | $307,000 | +1.0% | 16,200 | 0.0% | 0.00% | – |
Q3 2015 | $304,000 | +128.6% | 16,200 | +81.2% | 0.00% | – |
Q2 2015 | $133,000 | – | 8,940 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |